We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
in silico ADME prediction
Product News

in silico ADME prediction

in silico ADME prediction
Product News

in silico ADME prediction


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "in silico ADME prediction"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

ACD/ADME Suite is a collection of software modules that provide predictions of properties relating to the pharmacokinetic profiling of compounds.

Predict P-gp specificity, oral bioavailability, passive absorption, blood barrier permeation, distribution, P450 inhibitors, CYP3A4 specificity, maximum recommended daily dose, solvation parameters, and more.  Predictions are based on a combination of expert knowledge, scientific intuition, and QSAR modelling.  An estimation of prediction reliability is provided, and training allows accuracy to be extended to proprietary chemical space.

Reduce the need for expensive, labor-intensive experimental testing, and focus research efforts on molecules that meet property requirements. ACD/ADME Suite is a better way to turn data into decisions.

Advertisement